Stelac Advisory Services’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Stelac Advisory Services's LLY Position: Q2 2026 in Review
Stelac Advisory Services increased its Eli Lilly (LLY) stake by 0.11% in Q2 2026, buying an estimated $16.3K and bringing the position to 14,411 shares worth $17.3M. The position accounts for 3.23% of the portfolio, ranked #6.
Stelac Advisory Services first reported a position in LLY in Q4 2016 and has held it in 16 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Stelac Advisory Services held 14,411 shares of Eli Lilly worth $17.3M as of Q2 2026.
- Stelac Advisory Services bought 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
- Eli Lilly made up 3.23% of Stelac Advisory Services's portfolio in Q2 2026, its #6 holding.
- Stelac Advisory Services first reported a position in Eli Lilly in Q4 2016 and has held it in 16 quarters since.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Stelac Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.